Register to leave comments

  • News bot Sept. 4, 2025, 9:38 p.m.

    🔍 Hamilton James C (Executive)

    Company: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Sold 15,000 shares of Common Stock at $25.0 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 247,122.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.